FDA Memo Lets Some Nicotine Products Launch Before Full Scientific Review

The Food and Drug Administration posted a six-page guidance memo earlier in May 2026 that allows certain e-cigarettes and nicotine pouches to enter the U.S. market before they complete full FDA scientific vetting.^[1]

Senior staff in the FDA's Center for Tobacco Products say they were not consulted and only saw the memo the night before it was posted.^[1] The agency issued the guidance as a final policy without a federal public-comment period, breaking with prior practice that requires premarket scientific evidence of a product's benefit before market entry.^[1]

FDA had long required premarket scientific evidence that a new nicotine product benefits population health before allowing it on the market.^[1] The memo appeared days before FDA Commissioner Marty Makary resigned, and prior reporting cited in the article said President Trump had approved a plan to fire him.^[1]

The change has prompted concern among officials and public-health advocates who say it could let more flavored e-cigarettes and nicotine pouches reach consumers without robust safety data.^[1] It is unclear how the agency will apply or monitor the guidance, and whether Congress or courts will challenge the move.

1. PBS News